ProQR Therapeutics N.V. SEC filings PRQR
ProQR Therapeutics N.V. has 391 filings in SEC EDGAR's recent list, going back to Jul 11, 2014. Its latest annual report, Form 20-F, was filed on Mar 12, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 28, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Jul 15, 2026 | — |
| F-3 | Shelf registration (foreign issuer) | Jul 6, 2026 | — |
| 424B5 | Prospectus supplement | Jun 26, 2026 | — |
| 424B5 | Prospectus supplement | Mar 25, 2025 | — |
| S-8 | Employee stock plan registration | Mar 13, 2025 | — |
| F-3 | Shelf registration (foreign issuer) | Mar 13, 2025 | — |
| 424B5 | Prospectus supplement | Oct 24, 2024 | — |
| 424B5 | Prospectus supplement | Oct 23, 2024 | — |
| 424B5 | Prospectus supplement | Oct 10, 2024 | — |
| F-3 | Shelf registration (foreign issuer) | Sep 30, 2024 | — |
| 424B5 | Prospectus supplement | Apr 24, 2023 | — |
| F-3 | Shelf registration (foreign issuer) | Mar 29, 2023 | — |
| 424B5 | Prospectus supplement | Mar 10, 2022 | — |
| F-3 | Shelf registration (foreign issuer) | Mar 1, 2022 | — |
| 424B5 | Prospectus supplement | Nov 17, 2021 | — |
| 424B5 | Prospectus supplement | Nov 17, 2021 | — |
| S-8 | Employee stock plan registration | Nov 4, 2021 | — |
| F-3 | Shelf registration (foreign issuer) | Nov 4, 2021 | — |
| F-3 | Shelf registration (foreign issuer) | Nov 4, 2021 | — |
| 424B5 | Prospectus supplement | Apr 1, 2021 | — |
| 424B5 | Prospectus supplement | Apr 1, 2021 | — |
| 424B5 | Prospectus supplement | Mar 30, 2021 | — |
| 424B5 | Prospectus supplement | Sep 22, 2020 | — |
| F-3 | Shelf registration (foreign issuer) | Sep 11, 2020 | — |
| 424B5 | Prospectus supplement | Mar 31, 2020 | — |
| 424B5 | Prospectus supplement | Oct 17, 2019 | — |
| 424B5 | Prospectus supplement | Oct 16, 2019 | — |
| F-3 | Shelf registration (foreign issuer) | Nov 7, 2018 | — |
| 424B5 | Prospectus supplement | Sep 7, 2018 | — |
| 424B5 | Prospectus supplement | Sep 5, 2018 | — |
| 424B5 | Prospectus supplement | Nov 15, 2017 | — |
| 424B5 | Prospectus supplement | Nov 15, 2017 | — |
| 424B5 | Prospectus supplement | Nov 13, 2017 | — |
| 424B5 | Prospectus supplement | Jun 30, 2017 | — |
| F-3 | Shelf registration (foreign issuer) | Oct 2, 2015 | — |
| S-8 | Employee stock plan registration | Oct 17, 2014 | — |
| 424B4 | Prospectus | Sep 19, 2014 | — |
| FWP | Free writing prospectus | Sep 18, 2014 | — |
| F-1MEF | Form f-1 462b | Sep 17, 2014 | — |
| F-1/A | Filing | Sep 17, 2014 | — |
| F-1/A | Filing | Sep 16, 2014 | — |
| F-1/A | Filing | Sep 8, 2014 | — |
| F-1 | Registration statement (foreign issuer) | Aug 14, 2014 | — |
Showing 43 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PRQR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Netherlands
- Headquarters
- Leiden
- SEC filer status
- Accelerated filer
- SEC CIK
- 1612940
- Former names
- ProQR Therapeutics B.V. (until Oct 3, 2014)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.